Partner news
News
Partner news
Ultromics Announces Collaboration with Janssen to Develop AI for Patients with Amyloidosis with Cardiac Involvement
Read full storyPartner news
F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics
Read full storyJNJ Press releases
Johnson & Johnson Innovation becomes a leading partner of Sitem Startup Club
Read full storyPartner news
Whole Genome Sequencing data on 200,000 UK Biobank participants are made widely available for research
Read full storyPartner news
Koa Health to collaborate with Janssen: Official press release
Read full storyPartner news
BioMed X Institute starts new project in immunology research with Janssen
Read full storyPartner news
Alderley Park launches breakthrough Oncology Development Programme in collaboration with Cancer Research UK, Innovate UK, Medicines Discovery Catapult and global pharma and healthcare companies
Read full storyPartner news
Syndesi Therapeutics announces successful completion of first-in-human Phase I study of novel SV2A modulator, SDI-118, in development for the treatment of cognitive impairment.
Read full storyPartner news
Vifor Pharma enters into commercial collaboration in the US with Janssen
Read full storyPartner news
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
Read full storyJNJ Press releases
Johnson & Johnson Innovation Announces Winners of the Seoul Innovation QuickFire Challenge: Robotics & Digital Surgery in Collaboration with Seoul Metropolitan Government and KHIDI
Read full storyJNJ Press releases
Johnson & Johnson Innovation Announces Winners of the Seoul Innovation QuickFire Challenge: Robotics & Digital Surgery in Collaboration with Seoul Metropolitan Government and KHIDI
Read full storyPartner news
Ad Scientiam announces agreement with Johnson & Johnson Innovation to develop a digital assessment scale for Major Depressive Disorders
Read full storyJNJ Press releases